RxSight RXST
NASDAQ RXST
$5.98 -0.18 (-2.92%)
At close: Aug 20, 2026 · 1:26 PM UTC

RxSight (RXST) Free Cash Flow Growth (5y) (2025 - 2026)

RxSight (RXST) Free Cash Flow Growth (5y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.07 Bn 193.46 Bn 7.27 Bn
2 Stryker 127.90 Bn 124.43 Bn 4.50 Bn
3 Medtronic 118.84 Bn 109.62 Bn 6.41 Bn
4 Boston Scientific 73.33 Bn 72.79 Bn 3.85 Bn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn
6 Dexcom 34.46 Bn 32.51 Bn 830.00 Mn
7 GE HealthCare Technologies 33.91 Bn 31.81 Bn 2.18 Bn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn
9 Steris 23.12 Bn 22.64 Bn 684.20 Mn
10 RxSight 248.32 Mn -155.92 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 2.13%
Mar 31, 2026 -1.62%
Dec 31, 2025 25.88%
Sep 30, 2025 16.05%